AFLAC INC (AFL)

Aflac Incorporated, a Georgia-incorporated holding company founded in 1973, provides supplemental health and life insurance products to millions of policyholders in Japan and the United States, operating through two reportable segments: Aflac Japan and Aflac U.S. Aflac Japan, the principal earnings contributor to the consolidated company, is the largest insurer in Japan by cancer and medical (third sector) policies in force, offering third sector products (cancer, medical, income support, nursing care, and work leave insurance) alongside first sector protection- and savings-type life insurance products (including whole life, term life, WAYS, and child endowment policies). Aflac Japan distributes products through approximately 7,000 traditional sales agencies with about 113,000 licensed associates, alliance partnerships with Dai-ichi Life (~37,000 representatives) and Daido Life, the Japan Post Group network (over 20,000 postal outlets), and agreements with roughly 90% of Japanese banks. Aflac U.S., comprising subsidiaries American Family Life Assurance Company of Columbus (Aflac), Continental American Insurance Company (branded Aflac Group Insurance), American Family Life Assurance Company of New York, Tier One Insurance Company, and Aflac Benefits Solutions, offers supplemental coverage—including accident, disability, cancer, critical illness, hospital indemnity, dental/vision, and life insurance—on individual and group bases, distributed via independent career agents targeting small businesses and brokers serving mid- to large-case employers (with an average of ~6,200 actively producing U.S. agents in 2023), as well as growing direct-to-consumer digital channels.

The company's marketing is anchored by the iconic Aflac Duck, which has driven brand recognition in both markets since its 2000 U.S. debut and 2003 Japan debut. Aflac is authorized to conduct insurance business across all 50 U.S. states, the District of Columbia, several U.S. territories, and Japan, and faces regulatory oversight from Japan's Financial Services Agency (including solvency margin ratio requirements and the Japan Companies Act governing dividend distributions) as well as U.S. state insurance regulators governing licensing, policy forms, capital requirements, and holding company transactions. The company competes based on product design, pricing, service, distribution breadth, and brand strength amid an increasingly competitive landscape as major medical carriers seek entry into supplemental insurance markets.

The filing outlines numerous risk factors that could affect forward-looking projections, including capital market volatility, interest rate and currency fluctuations (particularly yen/dollar exposure given business concentration in Japan), credit and investment valuation risks, regulatory and legal changes, cybersecurity threats, competitive pressures, catastrophic events, and execution risks related to technology and distribution initiatives.